COVID-19 Impact Review: What Challenges Antidiabetics Market May See In Next 5 Years?

 The impact of coronavirus pandemic on the global Antidiabetics market has proved to be quite positive. Unavailability of cure for diabetes and vulnerability of diabetic patients to COVID-19 has enhanced the demand for anti-diabetic drugs across the global. The key players of the market are predicted to unleash myriads of opportunities for the growth of the market in the forthcoming years by their smart strategies.

The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global antidiabetics industry. This is a professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/339

• Highlights of the Report

A significant growth has been recorded by the global antidiabetics market in the recent years. The report reveals that the industry is estimated to garner a revenue of $148.3 million by the end of 2027, at a CAGR of 11.1% during the forecast period.

The unprecedented outbreak of coronavirus has helped the growth of the market in a fairly positive way. During the crisis, the market has collected a revenue of $70.9 million owing to the growing demand of anti-diabetic drugs.

• Factors Driving the Market Growth amid COVID-19 Pandemic

As our analysts observe, the growing cases of diabetes and non-availability of the perfect treatment for diabetes has compelled people to look for the anti-diabetics drug. Moreover, people with diabetes are more vulnerable to coronavirus. These are the factors driving the growth of global antidiabetics market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/339

• Future Scope of the Market

According to the report, the global antidiabetics market is projected to maintain a sustainable growth post the pandemic.

New entrants and leading players including Eli Lilly and Company, Sanofi, Johnson & Johnson Services, Inc., Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited, Halozyme, Inc., Merck Sharp & Dohme Corp., Novartis AG, Bristol-Myers Squibb Company, Oramed and Pfizer Inc. among others.

The financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments of the key players are also highlighted in the report.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Is Neonatal Ventilator Market Trapped Between Growth Expectations And Uncertainty?

 The novel coronavirus (COVID-19) pandemic has positively impacted the global neonatal ventilator market. According to the World Health Organization (WHO), the world population aged 40 years and above are more prone to serious respiratory problems owing to coronavirus infection. In addition, these patients are needed to be treated with ventilator to overcome respiratory problems owing to which infection can be cured and treated. Thus, soon after the COVID-19 outbreak, many manufacturers all across the globe are entering into joint agreements to produce a large number of ventilators. Moreover, the government of various countries are taking initiatives to support the business during this pandemic situation. During this unprecedented situation, we at Research Dive are helping our clients in understand the impact of COVID-19 on the market.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/197

A new report by Research Dive states that the global neonatal ventilator market is set to grow at a CAGR of 7.1% and is projected to garner a revenue of $495.3 billion during the period of forecast from 2019 to 2026. The global market is segmented on the basis of product type, mode of ventilation, mobility type, technology, end user, and region. The report delivers in-depth insights on opportunities, vital segments, restraints, drivers, and prominent players of the global market. Our analysts stated that the growing prevalence of smoking, an increase in aged population, growing attentiveness related to technological development, and improvement in healthcare centers are the significant factors boosting the growth of global neonatal ventilator market. Conversely, high costs associated with neonatal ventilator system is expected to hamper the market growth during the forecast period. Moreover, growing prevalence of respiratory and neurological diseases and rising healthcare expenditure are likely to create enormous growth opportunities in the global industry in the coming years.

• Non-Invasive Ventilation Segment to Subjugate the Industry

On the basis of product type, the global market for neonatal ventilator is segmented into non-invasive and invasive ventilation. The non-invasive ventilation subjugated the overall market in 2018 and is expected to reach up to $163.5 billion during the forecast period. The dominance of this segment is attributed to growing adoption of non-invasive ventilators as it provides benefits such as increased tolerance, no requirement of skilled employee to operate, availability outside of ICU, convenient to use, and reduced cost.

• Combined Mode of Ventilation to Grow Exponentially

Depending on the mode of ventilation, the global industry is segmented into volume mode, combined mode, pressure mode, and others. The combined mode of ventilation segment is anticipated to rise at a CAGR of 7.7% and projected to garner $93.3 billion revenue during the period of forecast. This growth is mainly owing to increased versatility, auto PEEP, safe usage, reduced time for mechanical ventilation, decreased need of human manipulation, and prevention from causing Tachypnea.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/197

• High Frequency Ventilator to Expand at Fastest Rate

Based on the technology, the neonatal ventilator market is segmented into mechanical ventilator, hybrid ventilator, volume targeted ventilator, and high frequency ventilator. Of these, the high frequency ventilator segment is estimated witness the fastest growth with 7.9% CAGR and is expected to surpass $147.3 billion by 2026. Decreased frequency and increased oxygenation, fresh gas flow, and amplitude are expected to boost the need for high frequency ventilator and thereby propel the segmental market growth in the coming future.

• Portable/Transportable Ventilator Segment to Witness Considerable Growth

On the basis of mobility type, the global market for neonatal ventilator market is segmented into portable/transportable ventilators and intensive care ventilators. The portable/transportable ventilators segment is expected to generate $181.3 billion and grow at a CAGR of 7.7% during the forecast period. On the other hand, the intensive care ventilator are extensively used due to its beneficial factors such as advanced installation of caps, leak compensation, and proximal flow sensor that rises the precision of measurement.

• Clinical Segment to be Most Lucrative

Based on the end use, the global neonatal ventilator industry is segmented into ambulatory surgical centers, clinics, hospitals, and others. The clinics segment accounted for $34.6 billion in 2018 and is estimated to rise at a CAGR of 8.1% during the period of forecast. This segment is projected to garner a revenue of $64.1 billion by 2026 owing to growing prevalence of respiratory and neurological diseases.

• Major Market Players

Some of the key players functioning in the global neonatal ventilator market include Becton, Philips Healthcare, ResMed, Drager, Fisher & Paykel, Hamilton Medical Devices, Allied Healthcare Products, Air Liquide Medical Devices, Smiths Medical, and Getinge AB.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Outbreak: How Organ Care System Market For Lungs Will Shape Having Biggies with Strong Fundamentals?

 The spread of the COVID-19 pandemic has brought a positive impact on the global organ care system for the lungs industry. Lung transplantation is still witnessing newer heights in the global market. Key players are highlighting mainly on the newer and innovative business strategies to strengthen the footprint in the market during and post-pandemic period.

The recently published research report by Research Dive reflects on the influence of COVID-19 pandemic on the present and forthcoming growth of the global organ care system for lungs industry. This is professional and all-inclusive research articulated by specialists by evaluating the major growth driving factors, important regional market situations, future opportunities and scope, and trends & developments in the market during the COVID-19 outbreak.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/341

• Highlights of the Report:

The market is anticipated to perceive growth owing to the mounting demand for increasing adoption of organ care system for lungs in the healthcare industry due to enhanced security for lung transplants during the course of the pandemic.

Significant growth has been recorded by the global organ care system for lungs market in recent years. The report reveals that the global organ care system for the lungs industry is estimated to garner a revenue of $6,577.5 million by the end of 2026, at a CAGR of 21.8% during the forecast period. The unprecedented outbreak of coronavirus has helped the growth of the market in a fairly positive way. During the crisis, the market has collected a revenue of $2,065.6 million in 2020, crossing the pre-COVID market estimations of $1,960.7 million owing to the importance of organ care against lung failure.

• Factors Driving the Market Growth amid COVID-19 Pandemic:

As per the estimation of our analyst, the rising adoption of the organ care system for the lungs system by patients with lung failure is attributing to the growth of the global organ care system for lungs industry during this hard time. The latest report published by Research Dive on the global organ care system for lungs market reveals the impact of COVID-19 pandemic on market growth. Before the rise of the pandemic, the market was expected to grow at a CAGR of 19% from 2020 to 2026. However, the sudden outburst of the COVID-19 pandemic has fueled market growth. Market experts have estimated that the market will grow at a growth rate of 21.8%, post-COVID-19 upheaval.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/341

• Current COVID-19 Impacted Scenario of the Market:

According to the report, the global organ care system for lungs market is projected to maintain a sustainable growth post the pandemic. Some of the significant organizations are mainly focusing on R&D and product launching to stay safe for the post-pandemic impact of the COVID-19. For instance, new clinical research has shown that one-third of ventilated patients have decreased deaths by new drug dexamethasone, which suppresses the immune system worldwide. The leading players of the market are focused on developing new, innovative strategies to sustain market growth.

• Future Scope of the Market:

The system of organ care aims to protect the donor organ and reduces the time for the immediate donation. These devices will monitor for the organ needed and keep it available for transplantation if and when necessary. In order to develop increased security during transplantations, scientists continue to make significant improvements to the healthcare industry. That has led to the expansion of the market for lungs in organ care systems over the last few years.

The leading players and new entrants are expected to bring in some newer innovative advances and rewarding opportunities for the market in upcoming years. The report offers the following information of the major players in the market: business overview – financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

The COVID-19 Fallout: Medical Pendant Market in 2020 - What Does the Year Ahead Hold?

 The COVID-19 pandemic has impacted the global medical pendant market in a positive way. The reason attributing to the growth of the market is the surge in the medical engagement of COVID-19 patients and increasing demand of smart and effective patient care 24/7. The leading players of the market are focusing on developing strategies to sustain the market growth in the post-pandemic market.

The latest research report on the global medical pendant market by Research Dive reflects the influence of COVID-19 pandemic on the present and forthcoming growth of the global market. This report is a professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/358

• Highlights of the Report

– As per a pre-COVID analysis, the market was expected to garner a CAGR of 7.3% during the forecast period.
– The real-time CAGR of the market is 8.1% according to the latest report for the forecast period.
– The market was estimated to reach a revenue of $ 439.2 million in 2020 as per the pre-pandemic analysis.
– The real-time global market has garnered a revenue of $450.5 million.

• Factors Attributing to the Growth of the Market

As per our analysts, rapidly growing demand for medical pendants along with hike in government investments to improve hospital amenities are fueling the market growth. Apart from that, the growing numbers of COVID-19 patients in hospitals and the need for undivided attention and care of these patients have increased the demand for medical pendants.

• Impact of COVID-19 of the Market and Current Scenario

The leading players of the market are focused on developing new, innovative strategies to sustain the market growth. For example, in May 2019, European investment bank (EIB) has lend about $129 million to Drager, a leading company in medical and safety technology, for R&D investments to improve medical technology development.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/358

• Future Scope of the Market

According to the report, the global medical pendant market is projected to maintain a sustainable growth post the pandemic. New entrants and leading players are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report also summarizes other important aspects of the key players including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Corona Impact: Is Pneumonia Therapeutics Market will Propel with its Advanced Approaches in 2020

 The coronavirus outbreak has impacted the global pneumonia therapeutics market in a positive way. The main reason behind this growth is the non-availability of treatment for COVID-19. The leading players of the market are focusing on developing strategies to sustain the market growth in the post-pandemic market.

The latest research report on the global pneumonia therapeutics market by Research Dive reflects the influence of COVID-19 pandemic on the present and forthcoming growth of the global market. This report is a professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/357

• Highlights of the Report

– As per the previous report, the global pneumonia therapeutic market was expected to grow at a CAGR of 7.8% during the forecast period.
– The real-time CAGR has been recorded at 8.2% in a new analysis.
– The market was estimated to reach $1,783.1 million in 2020 as per the pre-pandemic analysis.
– The real-time (2020) market size has reached a revenue of $1,817.1 million.

• Factors Accelerating the Growth of the Market

The primary factor behind the growth of the global pneumonia therapeutics market is obviously the increasing transmission of the highly infectious and fatal virus. Pneumonia being the most prevalent symptom of COVID-19, the demand for pneumonia therapeutics has been increased.

• Current COVID-19 Impacted Scenario of the Market:

The leading players of the market are focused on developing new, innovative strategies to sustain the market growth. For instance, BioAegis therapeutics has recently received approval to proceed with phase 2 trial of its gelsolin COVID-19 Treatment. Gelsolin is a key component of the body’s immune system. BioAegis is in a unique position to deliver therapeutics that have the potential to disrupt the course of the cytokine storm created by COVID-19.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/357

• Future Scope of the Market:

According to the report, the global pneumonia therapeutics market is projected to maintain a sustainable growth post the pandemic. New entrants and leading players are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report also summarizes other important aspects of the key players including financial performance, product portfolio, SWOT analysis, and recent strategic moves and developments.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

How Viscosupplementation Market Will Grow In Coming Future Despite COVID-19 Chaos?

 The abrupt occurrence of the COVID-19 pandemic has imposed a positive impact on the global viscosupplementation market growth in 2020. Growing demand for viscosupplementation for treating osteoarthritis patients is boosting the growth of the market. Analysts have anticipated that market will observe incessant growth after the end of the COVID-19 disaster.

• Scenario of the Market before and after COVID-19 Pandemic:

Research Dive has added a new report on the global viscosupplementation market to its repository. The report reveals the impact of COVID-19 pandemic on the growth of the market. Before the rise of the pandemic, the market was estimated to grow at a CAGR of 10.2% from 2019 to 2026. Nevertheless, the unexpected outburst of COVID-19 pandemic has boosted the growth of the market. Market professionals have projected that the market will grow at a CAGR of 10.6% and garner $5,866.2 million, after the end of COVID-19 pandemic. This is mainly due to the rising demand for viscosupplementation due to rising cases of osteoarthritis in elderly population.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/342

• Present Scenario of the Market during COVID-19 Crisis:

Before the outbreak of the pandemic, the global viscosupplementation market was expected to hit $2,845.3 million in 2020. However, in the current circumstances, i.e. in 2020, the market size has stretched up to $2,903.3 million. The rise in the growth of the market is chiefly owing to the mounting demand for viscosupplementation for treating osteoarthritis patients. Amidst this crisis period, a significant rise in the number of osteoarthritis cases particularly in the elderly population has been witnessed. As per a publication by the United Nations (UN), by 2050, about 130 million people are likely to suffer from osteoarthritis worldwide.

• Top Players of the Market:

Some of the major players active in the viscosupplementation market are Anika Therapeutics, Inc., OrthogenRx, Bioventus., Fidia Farmaceutici S.p.A., Aptissen, ecnofarma S.A., Zimmer Biomet, TRB Chemedica International SA, Stellar Pharmaceuticals Inc., and Dr. Reddy’s Laboratories Ltd. Additionally, the report outlines the business overview including financial performance, recent strategic moves & developments, product portfolio, and SWOT analysis of all key players of the market.

As a response to COVID-19 catastrophe, market players are devising numerous business strategies, for instance, strategic agreements, technological inventions, and collaborations to survive their business. For example, OrthogenRx, Inc., a medical device manufacturing company has announced the initialization of patient programs called TriVisc Direct Purchase Program and TriVisc Patient Assistance Program, in May 2020.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/342

• Outlook of the Market Post COVID-19 Pandemic:

As per market researchers, the global viscosupplementation market is expected to continue to grow at a significant growth rate after the end of the COVID-19 crisis. This is mainly due to an upsurge in the number of sports related joint injuries owing to growing adoption of sports in upcoming years. Additionally, growing technological advances and increasing investments in the viscosupplementation technology are estimated to unlock rewarding opportunities and boost the growth of the global viscosupplementation market after the end of the COVID-19 pandemic.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

How COVID-19 Pandemic Will Impact on Critical Care Devices Market Growth in 2020 and Coming Future?

 The coronavirus outbreak has influenced the critical care devices industry fairly and positively. Expanded usage of critical care devices is expected to fuel the demand for COVID-19 care during the forecast era. Markets are projected to provide investors with more growth prospects over time. Leading players of the market are predicted to unlock vibrant opportunities for the growth of the market in the forthcoming years by taking various initiatives.

The latest research report on the global critical care devices market by Research Dive reflects the influence of COVID-19 pandemic on the present and expected growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/340

• Highlights of the Report:

The global critical care devices market has witnessed remarkable growth in the previous years. The sudden outbreak of COVID-19 has impacted the market, bringing even more chances of growth. As per the report, the global critical care devices industry is expected to register a revenue of $41.5 million by 2027, at a growth rate of 3.2% during the forthcoming years. In the current situation, the market has garnered $33.3 million in 2020, owing to the increasing demand for critical care devices across the healthcare industry.

• Factors Driving the Market Growth amid COVID-19 Pandemic:

As per our analyst estimates, the growth of the global critical care devices industry is majorly attributed to the significantly rising adoption of critical care devices system by the healthcare industry. However, high costs to obstructing the growth of the critical care devices industry.

The report discloses the real-time CAGR recorded by the market during the pandemic. According to the report, the critical care devices market has earned a CAGR of 3.2% during the last few months of the crisis, while the pre-COVID-19 estimation was only 3%. The reason behind this growth is the growing necessity of growing adoption of critical care devices in the healthcare industry owing to longer life cycles.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/340

• Current COVID-19 Impacted Scenario of the Market:

The leading players of the market are focused on developing new, innovative strategies to sustain market growth. To drive the demand during the pandemic, innovation in critical care instruments that are used in surgical procedures, and an increase in intensive care units has allowed healthcare institutions to provide better healthcare services for the patient. It is expected that a lack of skilled labor to operate such tools would hamper the demand in the forecast period.

• Future Scope of the Market:

According to the report, the global critical care devices market is projected to maintain sustainable growth post the pandemic.

New entrants and leading players including GE Healthcare, Cardinal Health, Breas Medical, Boston Scientific Corporation, Biometrix, Asahi Kasei Corporation, Airon Corporation, Air Liquide Medical Systems, Biometrix and Avanos Medical, Inc, among others are expected to bring in some newer innovative advances and rewarding opportunities for the market in next few years. The report summarizes the following aspects of all key players: business overview – financial performance, product portfolio, recent strategic moves & developments, SWOT analysis.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Potential Impact of COVID-19 on Organ Care System Market: What to Expect from Industry in 2020?

 The COVID-19 outbreak has helped the global organ care system market to grow at a positive rate. The manufactures of the industry are investing more in R&D activities to grow exponentially during the forecast period.

The COVID-19 pandemic has positively impacted the global Organ care system (OCS) for liver market and a slight increase in the growth rate is observed from the previous predictions. As per new Research Dive published report, the global OCS for liver market is anticipated to grow at a CAGR of 9.3% by 2026, generating a revenue of $42.7 million in the period of forecast from 2019 to 2026. To better understand the pandemic effect on the global market, the report includes comprehensive analysis on growth opportunities, restraints, drivers, vital segments, and strategies adopted by major market players.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/253

• Highlights of the Report

As per our analysts, the rising cases of end stage liver failure coupled with the increasing number of liver transplants carried out all over the world is a significant factor impelling the growth of global OCS for liver market. The projected market size for the OCS for liver industry prior to COVID-19 chaos was $24.8 million in 2020 and this number is predicted to increase up to $25.2 million post-coronavirus pandemic. The growing prevalence of chronic diseases in liver and the rising consumption of alcohol are other factors responsible for the market growth. Conversely, the unavailability of donors and the high costs associated for treatment of liver disease are likely to restrict the market growth during the forecast period.

• Implementing Several Strategies to Grow Exponentially Pandemic Crisis

The leading players of the OCS for liver industry OrganOx Limited, TransMedics Inc., Preservation Solution Inc., Organ Assist B.V., Organ Transport System Inc., Preservation Solution Inc., Bridge to Life Ltd., Paragonix Technologies Inc., Water Medical System LLC, Organ Recovery Systems Inc., and XVIVO Perfusion AB. These players are investing more in research and development activities to grow exponentially and maintain a strong market position.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/253

For instance, Transmedics along with J.P Morgan and Morgan Stanley initiated offering successive trials showing decreased complications in transplant of liver.

Moreover, in January 2019, the UK national institute for health and care approved the liver perfusion machine of OrganOx. This technology is addressed as a ‘game changer’ by many industry experts.

• Global Industry to Witness Impressive Growth Post-COVID-19 Chaos

Research Dive states that the global OCS for liver market is anticipated to experience a robust growth post-coronavirus pandemic. In order to meet the demand of supply, the manufacturers of the industry are taking efforts t advance and improve the organ care systems. Moreover, the rising demand for OCS and the growing cases of liver chronic diseases are factors predicted to propel the market growth after COVID-19 pandemic.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Why Dynamics of Medical Tourism Market Is Changing Drastically? What If History Is Any Guide?

 the covid-19 crisis has affected the global medical tourism market in a negative way. the governments are taking initiatives to help patients seek healthcare treatment and the market is likely to recover by q1/q2 of 2022.

The COVID-19 pandemic has hugely impacted the global medical tourism market and a slight downfall is witnessed in the growth rate as compared to the former predictions. As per new Research Dive published report, the global medical tourism market is anticipated to rise at a CAGR of 11.7% by 2026, generating a revenue of $142.2 billion in the period of forecast from 2019 to 2026. While there is a decrease in the growth rate due to the COVID-19 outbreak, the market is likely to recover by Q1/Q2 of 2022.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/248

• Highlights of the Report

As per our analysts, the increasing interests amongst people coupled with technological advancements in healthcare treatment is a significant factor impelling the growth of global medical tourism market.

The projected market size for the medical tourism industry prior to COVID-19 chaos was $73.7 billion in 2020 and this number is expected to drop down to $44.2 billion post-coronavirus pandemic. The risk associated with travel after surgery, language barrier, and quality of staff members will hinder the market growth in the coming years.

Conversely, the rising interests of people towards better quality healthcare coupled with advanced technology and low cost will propel the demand for medical tourism during the forecast period.

• Sustaining in the Pandemic Situation

A number of countries all over the world are inviting well known medical specialists Cleveland Clinic, Mayo Clinic, and Harvard Medical International by investing more to develop medical tourism facilities.

Furthermore, other countries are adopting diverse strategies in order to fuel the growth of medical tourism market. For instance, India launched visa facilities for foreigners namely, ‘M-visa,’ to allow foreigners to enter the country for healthcare treatment.

In addition, the doctors in Singapore are treating people to maximum of three diverse locations, which is based on the guidelines of Ministry of Health (MOH) to stop the spread of COVID-19 virus.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/248

The leading players of the medical tourism industry include Anadolu Medical Centre, Shouldice Hospital, Clemenceau Medical Centre, Prince Court Medical Centre, Gleneagles Global Hospitals Group, and Bangkok Hospital.

• Global Industry to Witness Significant Growth Post-Coronavirus Chaos

Research Dive states that the global medical tourism market is projected to witness considerable growth post-COVID-19 pandemic. There are various benefits associated with medical travel such as availability of better-quality medical treatment, accessibility of medication, and low costs, which will surge the demand for medical tourism during the forecast period.

Moreover, various countries such as Thailand, India, and Singapore are gaining importance due to availability of low-cost healthcare treatment, which is predicted to propel the market growth after COVID-19 pandemic.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

COVID-19 Impact: What Challenges Antiviral Therapy Market May See In Next 5 Years?

 The rise of COVID-19 pandemic has positively impacted the global antiviral therapy market in 2020. Rising research & development and advances in the production of antiviral drugs is fueling the growth of the market during COVID-19 crisis.

A new report by Research Dive deliberates the impact of COVID-19 on the present and future growth of the global antiviral therapy market. This report is formulated by market professionals by considering all the important factors such as regional market conditions, current trends & developments, market drivers and restraints, and size & scope of the market. This report is a valuable source of information and guidance for professionals involved in this market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/246

• Key Highlights of the Report:

The COVID-19 pandemic has imposed a positive impact on the global market for antiviral therapy. As per the report, the global antiviral therapy market was valued at $48.1 million in 2018 and is estimated to gather $79.8 million by soaring at a growth rate of 6.7% by 2026. In the present condition, the market has collected a revenue of $54.7 million owing to the growing demand for antiviral drugs for treating COVID-19 patients.

• Factors Boosting the Market Growth amidst Covid-19 Pandemic:

As per the report, factors such as growing investments in R&D of antiviral therapies, effectiveness of antiviral drugs to treat COVID-19 infection, and rising interest of pharmaceutical firms in the manufacture of antiviral drugs are fueling the growth of the global antiviral therapy market. Furthermore, increasing demand for antiviral drugs from numerous countries is boosting the growth of the global industry.

• Current Market Situation Due to COVID-19:

Some of the foremost companies operating in this market are working on the development of more advanced medicines. Moreover, some top players are entering into partnerships and collaborations to expand their business in the course of the crisis period. For example, in May 2020, Cipla, a leading multinational pharmaceutical company has collaborated with Gilead Sciences for the production and supply of the investigational drugs used in the treatment of COVID-19 patients. The company has also joined hands with the Hyderabad-based Indian Institute of Chemical Technology (IICT) to manufacture anti-viral drugs for treating COVID-19 infection.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/246

Furthermore, in April 2020, Ennaid Therapeutics, LLC, a leading biopharmaceutical venture has declared that they are advancing the manufacture of ENU200 for the treatment of COVID-19 affected patients. Such initiatives undertaken by key players are leading to the growth of the global antiviral therapy market.

• Future Scope of the Market:

As per analysts, the global antiviral therapy industry is projected to experience incessant growth post-COVID-19 crisis owing to the predicted rise in the demand for antiviral drugs. New entrants and some of the foremost players including AbbVie Inc., Inc., Johnson & Johnson Services, GlaxoSmithKline plc., Gilead Sciences, Inc., Merck & Co., Inc., Informa plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., and others are likely to come up with ground-breaking developments and unlock profitable opportunities for the growth of the market growth in the coming future.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com

Corona Impact: Is Assisted Reproductive Technology Market will Propel at a Defining Pace 2020

 The worldwide spread of COVID-19 has positively impacted the global assisted reproductive technology market. This is mainly due to supportive government policies and the strategic steps taken by major market players in the pandemic crisis. For instance, in June 2020, SART launched its fertility expert’s podcast series. Furthermore, the global market is expected to observe substantial growth even after the pandemic owing to the growing adoption of R&D and growing awareness amongst people regarding assisted reproductive technology.

The global assisted reproductive technology market is likely to experience an increase in the growth rate during the COVID-19 pandemic. As per a new report added by Research Dive, the global assisted reproductive technology market is anticipated to reach up to $56.3 billion during the forecast period from 2019 to 2026. Comprehensive analysis on drivers, challenges, growth opportunities, major segments, and key strategies executed by major market players are provided in the report for better understanding of the pandemic effect on the global market.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/345

• Highlights of the Report-

– The expected CAGR of the assisted reproductive technology market before COVID-19 pandemic was 10.3% during the forecast period.

– The CAGR of the global market after the pandemic crisis is projected to grow at a CAGR of 10.7% by 2027.

– In 2020, the expected market size of the assisted reproductive technology market before COVID-19 pandemic was $27.0 billion.

– Due to COVID-19 pandemic, the market size of the global market is expected to reach up to $27.6 billion in 2020.

• Key Features of the Market

Our analysts stated that the supportive government policies and rise in number of government approvals for assisted reproductive technology for infertile couples’ treatment are the major factors expected for progressive market growth. For instance, in February 2020, the Indian government passed ‘assisted reproductive technology (ART) regulation bill’ amidst the COVID-19 pandemic. The bill is approved by the government to regulate the ART clinics with an aim to offer ‘safe and ethical’ reproductive procedures to nearly 27 billion infertile couples in the country.

Furthermore, many institutions and organizations are coming forward their strategic steps in the pandemic crisis with an objective to help infertile couples. For instance, in June 2020, Society for assisted reproductive technology (SART) announced the launch of its fertility experts’ podcast series. Multiple topics regarding the fertility treatment are addressed in the podcast. The aim of SART is to offer patient-friendly education in order to help them in understanding fertility problems and treatment options. These initiatives by various organizations are predicted to create huge awareness amongst individuals, which is projected to drive the growth of the global assisted reproductive technology market during COVID-19 crisis.

For More Detail Insights, Download Sample Copy of the Report at: https://www.researchdive.com/download-sample/345

• Prominent Players of the Industry

The major players operating in the global assisted reproductive technology market include Merck KGaA, Nidacon International AB, Cook, California Cryobank, FUJIFILM Irvine Scientific, IVFtech ApS, CooperSurgical, Inc., Hamilton Thorne, Inc., Thermo Fisher Scientific Inc., and Ferring Pharmaceuticals. The report summarizes various aspects of all these key players including financial performance, product portfolio, recent strategic moves & developments, and SWOT analysis.

• Post-Pandemic Scenario

As per the report, the global assisted reproductive technology market is expected to witness a progressive growth even after the COVID-19 pandemic. The growing adoption of R&D and innovations and the increase in number of patients suffering from childlessness and infertility disorders are expected to boost the growth of the global market during the forecast period. Besides, the growing success rate of assisted reproductive technology is other factor likely to propel the market growth after COVID-19 pandemic. For instance, according to the statistics provided by SART, more than 74,000 babies were born in 2018 with the help of using assisted reproductive technology.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com
LinkedIn: https://www.linkedin.com/company/research-dive
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive
Blog: https://www.researchdive.com/blog
Follow us on: https://covid-19-market-insights.blogspot.com